Home |
Free Dividend Report |
Stock Splits Calendar |
VPHM Historical Stock Prices |
Preferred Stock Newsletter |
VPHM Options Chain |
VPHM Message Board |
VPHM (VPHM) has the following price history information. Looking back at VPHM historical stock prices for the last five trading days, on January 17, 2014, VPHM opened at $49.98, traded as high as $49.99 and as low as $49.97, and closed at $49.99. Trading volume was a total of 617.60K shares. On January 21, 2014, VPHM opened at $49.99, traded as high as $49.99 and as low as $49.97, and closed at $49.97. Trading volume was a total of 418.30K shares. On January 22, 2014, VPHM opened at $49.98, traded as high as $49.99 and as low as $49.97, and closed at $49.97. Trading volume was a total of 213.30K shares. On January 23, 2014, VPHM opened at $49.99, traded as high as $50.01 and as low as $49.96, and closed at $49.96. Trading volume was a total of 4.78M shares. On January 24, 2014, VPHM opened at $49.96, traded as high as $49.96 and as low as $49.96, and closed at $49.96. Trading volume was a total of 0 shares.
VPHM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into VPHM shares, starting with a $10,000 purchase of VPHM, and working forward through the historical stock price information to today. VPHM -- use the split history when considering split-adjusted past price performance.
VPHM Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
01/17/2014 | $49.98 | $49.99 | $49.97 | $49.99 | 617.60K |
01/21/2014 | $49.99 | $49.99 | $49.97 | $49.97 | 418.30K |
01/22/2014 | $49.98 | $49.99 | $49.97 | $49.97 | 213.30K |
01/23/2014 | $49.99 | $50.01 | $49.96 | $49.96 | 4.78M |
01/24/2014 | $49.96 | $49.96 | $49.96 | $49.96 | 0 |
About VPHM |
ViroPharma is a biotechnology company. Co. markets and sells Cinryze in the U.S. for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema. Co. also sells branded and authorized generic Vancocin HCl capsules, the oral capsule formulation of vancomycin hydrochloride, in the U.S. and its territories. Vancocin is indicated for the treatment of C. difficile-associated diarrhea (CDAD). Co.'s product development portfolio is primarily focused on these programs: C1 esterase inhibitor [human]; maribavir for cytomegalovirus infection; VP20621 for prevention of recurrent CDAD; and VP20629 for treatment of Friedreich's Ataxia. |
VPHM Historical Closing Prices | |
Date | Close |
01/17/2014 | $49.99 |
01/21/2014 | $49.97 |
01/22/2014 | $49.97 |
01/23/2014 | $49.96 |
01/24/2014 | $49.96 |
Healthcare Historical Prices |
VPHM is categorized under the Healthcare sector; below are some other companies in the same sector:
VRAY Historical Stock Prices
Free VPHM Email Alerts:
|
VPHM Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.